Ameritas Investment Partners’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80.1K | Hold |
7,304
| – | – | ﹤0.01% | 1975 |
|
|
2026
Q1 | $59.4K | Hold |
7,304
| – | – | ﹤0.01% | 1997 |
|
|
2025
Q4 | $75.9K | Hold |
7,304
| – | – | ﹤0.01% | 1859 |
|
|
2025
Q3 | $64.6K | Hold |
7,304
| – | – | ﹤0.01% | 1949 |
|
|
2025
Q2 | $42.1K | Hold |
7,304
| – | – | ﹤0.01% | 2295 |
|
|
2025
Q1 | $48.2K | Hold |
7,304
| – | – | ﹤0.01% | 2123 |
|
|
2024
Q4 | $63.6K | Hold |
7,304
| – | – | ﹤0.01% | 2041 |
|
|
2024
Q3 | $143K | Hold |
7,304
| – | – | ﹤0.01% | 1559 |
|
|
2024
Q2 | $150K | Hold |
7,304
| – | – | 0.01% | 1460 |
|
|
2024
Q1 | $156K | Hold |
7,304
| – | – | 0.01% | 1468 |
|
|
2023
Q4 | $105K | Buy |
7,304
+829
| +13% | +$8.15K | ﹤0.01% | 1701 |
|
|
2023
Q3 | $59.1K | Buy |
6,475
+1,716
| +36% | +$17.4K | ﹤0.01% | 1993 |
|
|
2023
Q2 | $50.4K | Hold |
4,759
| – | – | ﹤0.01% | 2052 |
|
|
2023
Q1 | $58.2K | Hold |
4,759
| – | – | ﹤0.01% | 1879 |
|
|
2022
Q4 | $66.5K | Hold |
4,759
| – | – | ﹤0.01% | 1868 |
|
|
2022
Q3 | $65K | Hold |
4,759
| – | – | ﹤0.01% | 1795 |
|
|
2022
Q2 | $87K | Sell |
4,759
-487
| -9% | -$7K | ﹤0.01% | 1605 |
|
|
2022
Q1 | $84K | Hold |
5,246
| – | – | ﹤0.01% | 1755 |
|
|
2021
Q4 | $73K | Hold |
5,246
| – | – | ﹤0.01% | 1879 |
|
|
2021
Q3 | $98K | Hold |
5,246
| – | – | ﹤0.01% | 1706 |
|
|
2021
Q2 | $109K | Hold |
5,246
| – | – | ﹤0.01% | 1676 |
|
|
2021
Q1 | $148K | Hold |
5,246
| – | – | 0.01% | 1407 |
|
|
2020
Q4 | $171K | Buy |
5,246
+560
| +12% | +$19.7K | 0.01% | 1237 |
|
|
2020
Q3 | $144K | Hold |
4,686
| – | – | 0.01% | 1214 |
|
|
2020
Q2 | $76K | Buy |
4,686
+1,833
| +64% | +$26.4K | ﹤0.01% | 1582 |
|
|
2020
Q1 | $28K | Hold |
2,853
| – | – | ﹤0.01% | 1989 |
|
|
2019
Q4 | $39K | Hold |
2,853
| – | – | ﹤0.01% | 2055 |
|
|
2019
Q3 | $43K | Buy |
2,853
+503
| +21% | +$8.95K | ﹤0.01% | 1974 |
|
|
2019
Q2 | $46K | Hold |
2,350
| – | – | ﹤0.01% | 1962 |
|
|
2019
Q1 | $39K | Hold |
2,350
| – | – | ﹤0.01% | 2027 |
|
|
2018
Q4 | $33K | Buy |
2,350
+630
| +37% | +$8.35K | ﹤0.01% | 2043 |
|
|
2018
Q3 | $30K | Hold |
1,720
| – | – | ﹤0.01% | 2288 |
|
|
2018
Q2 | $31K | Hold |
1,720
| – | – | ﹤0.01% | 2263 |
|
|
2018
Q1 | $32K | Buy |
1,720
+468
| +37% | +$9.11K | ﹤0.01% | 2178 |
|
|
2017
Q4 | $19K | Hold |
1,252
| – | – | ﹤0.01% | 2457 |
|
|
2017
Q3 | $9K | Hold |
1,252
| – | – | ﹤0.01% | 2816 |
|
|
2017
Q2 | $12K | Buy |
+1,252
| New | +$11.4K | ﹤0.01% | 2747 |
|
Other funds holding KURA
SCM
ACM
Ameritas Investment Partners's KURA Position: Q2 2026 in Review
Ameritas Investment Partners held its Kura Oncology (KURA) position steady in Q2 2026 at 7,304 shares worth $80.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.
Ameritas Investment Partners first reported a position in KURA in Q2 2017 and has held it in 37 quarters since. The position peaked at $171K in Q4 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.
- Ameritas Investment Partners held 7,304 shares of Kura Oncology worth $80.1K as of Q2 2026.
- Ameritas Investment Partners left its Kura Oncology share count unchanged in Q2 2026.
- Kura Oncology made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1975 holding.
- Ameritas Investment Partners first reported a position in Kura Oncology in Q2 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Kura Oncology position peaked at $171K in Q4 2020.
- 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.